The last decade has witnessed dramatic advances in our ability to determine the levels of an ever broadening range of metabolites. That said, while transcriptomic approaches provide almost complete coverage ([Gonzalez-Ballester et al., 2010][1]) and proteomics approaches are now capable of
No takes yet. Share an insight, caveat, or question.
Fernie et al. (2011) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: